Ligand validation:6L7S

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6L7S_NAG_A_502	61%	82%	0.142	0.93	0.35	0.44	-	-	0	0	100%	0.9333
6L7S_NAG_C_502	45%	80%	0.146	0.878	0.29	0.54	-	-	0	0	100%	0.9333
6L7S_NAG_A_503	29%	76%	0.203	0.861	0.28	0.66	-	1	0	0	100%	0.9333
6L7S_NAG_D_503	23%	84%	0.198	0.818	0.24	0.52	-	-	1	0	100%	0.9333
6L7S_NAG_B_502	9%	44%	0.26	0.762	1.07	1.09	1	2	0	0	93%	0.9333
6L7S_NAG_B_503	8%	76%	0.275	0.743	0.39	0.54	-	-	0	0	100%	0.9333
6L7S_NAG_D_502	7%	54%	0.291	0.753	0.89	0.89	1	1	0	0	100%	0.9333
6L7T_NAG_A_502	69%	81%	0.135	0.951	0.37	0.44	-	-	0	0	100%	0.9333
6KAN_NAG_A_502	66%	69%	0.13	0.936	0.67	0.53	-	-	0	0	100%	0.9333
6KAK_NAG_A_502	59%	85%	0.099	0.881	0.36	0.39	-	-	0	0	100%	0.9333
6L7U_NAG_A_502	50%	82%	0.117	0.867	0.36	0.44	-	-	0	0	100%	0.9333
6KAM_NAG_C_502	48%	81%	0.125	0.868	0.29	0.52	-	-	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.